In T2D and obesity conditions where insulin resistance is manifested, impaired insulin activity increases endogenous hepatic glucose production and decreases glucose uptake, thereby leading to glycotoxicity in organs such as adipose tissues and muscle [18,19]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.